Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
03/2006
03/07/2006US7008953 3-((mono- or di-fluoro-benzimidazol-2-yl))-5-(4-methyl-5-(ethylaminomethyl)pyrid-3-yl)indazole; inhibitors of cyclin dependent kinases(CDK) for use treating cancer and other proliferative disorders such as retinopathy, rheumatoid arthritis
03/07/2006US7008952 4-(phenyl-(piperidin-4yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
03/07/2006US7008948 Fused pyrimidyl pyrazole compounds useful as protein kinase inhibitors
03/07/2006US7008946 CCR5 antagonists useful for treating AIDS
03/07/2006US7008945 Amide derivatives
03/07/2006US7008943 1-(Pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives
03/07/2006US7008938 Benzene-fused heteroring derivatives and pharmaceutical agents comprising the same as active ingredient
03/07/2006US7008905 Method of combating undesired plant growth on cereals
03/07/2006US7008753 Optical recording medium
03/02/2006WO2006023931A2 Kinase inhibitors
03/02/2006WO2006023783A1 Novel anthranilamides useful for controlling invertebrate pests
03/02/2006WO2006023778A2 Small molecule inhibitors of anti-apoptotic bcl-2 family members and the uses thereof
03/02/2006WO2006023467A1 3-SUBSTITUTED-5- AND 6-AMINOALKYL INDOLE-2-CARBOXYLIC ACID AMIDES AND RELATED ANALOGS AS INHIBITORS OF CASEIN KINASE Iϵ
03/02/2006WO2006023462A1 Histamine h3 receptor agents, preparation and therapeutic uses
03/02/2006WO2006023460A2 COMPOUNDS HAVING β2 ADRENERGIC RECEPTOR AGONIST AND MUSCARINIC RECEPTOR ANTAGONIST ACTIVITY
03/02/2006WO2006023454A1 Crystalline form of a biphenyl compound
03/02/2006WO2006022773A1 Gyrase inhibitors and uses thereof
03/02/2006WO2006022442A1 Novel heterocyclic amide derivatives having dihydroorotate dehydrogenase inhibiting activity
03/02/2006WO2006022374A1 2-phenylpyridine derivative
03/02/2006WO2006022182A1 Method for producing 2-(4-methyl-2-phenylpiperazine-1-yl)-3-cyanopiridine
03/02/2006WO2006021883A2 Ventilation system and device for shoes
03/02/2006WO2006021881A2 Pyrazole-substituted aminoheteroaryl compounds as protein kinase inhibitors
03/02/2006WO2006021656A2 Aminopiperidine derivatives, preparation thereof and use thereof as melanocortin receptor agonists
03/02/2006WO2006021544A1 2,4-di(aminophenyl) pyrimidines as plk inhibitors
03/02/2006WO2006021457A2 Pyrimidine derivatives
03/02/2006WO2006021454A2 Pyrimidine derivatives
03/02/2006WO2006021448A1 Novel compounds having an anti-bacterial activity
03/02/2006WO2005123672A3 Kinase inhibitors
03/02/2006WO2005115984A3 Large conductance calcium-activitated k channel opener
03/02/2006WO2005113542A3 N-cyclic sulfonamido inhibitors of gamma secretase
03/02/2006WO2005101838A3 Piperazinylpiperidine derivatives as chemokine receptor antagonists
03/02/2006WO2005092895A3 Alpha aryl or heteroaryl methyl beta piperidino propanoic acid compounds as orl1-receptor antagonists
03/02/2006WO2005092858A3 Alpha aryl or heteroaryl methyl beta piperidino propanamide compounds as orl1-receptor antagonist
03/02/2006WO2005075457A8 Phthalazinone-derivatives as pde4 inhibitors
03/02/2006WO2005075456A8 2-(piperidin-4-yl) -4, 5-dihydro-2h-pyridazin-3-one derivatives as pde4 inhibitors
03/02/2006WO2005075437A8 Pyridazinone derivatives and their use as pde4 inhibitors
03/02/2006WO2005009989A8 Nicotinamide derivatives useful as pde4 inhibitors
03/02/2006US20060046999 Monocyclic aroylpyridinones as antiinflammatory agents
03/02/2006DE60108394T2 Sulfonyl-pyrrolidinderivate geeignet für die behandlung von neurologischen krankheiten Sulfonyl-pyrrolidine derivatives suitable for the treatment of neurological diseases
03/02/2006DE102004041163A1 Neue Verbindungen mit antibakterieller Aktivität New compounds with antibacterial activity
03/02/2006CA2578168A1 2-phenylpyridine derivative
03/02/2006CA2578122A1 Pyrimidine derivatives
03/02/2006CA2578075A1 Aminoheteroaryl compounds as protein tyrosine kinase inhibitors
03/02/2006CA2577251A1 Pyrimidine derivatives
03/02/2006CA2577191A1 4-heteroarylmethyl substituted phthalazinone derivatives
03/02/2006CA2577089A1 Sigma receptor inhibitors
03/02/2006CA2577061A1 Histamine h3 receptor agents, preparation and therapeutic uses
03/02/2006CA2576299A1 Method for producing 2-(4-methyl-2-phenylpiperazine-1-yl)-3-cyanopiridine
03/02/2006CA2575670A1 Aliphatic amide & ester pyrazinoylguanidine sodium channel blockers
03/02/2006CA2574454A1 Aminopiperidine derivatives, preparation thereof and use thereof as melanocortin receptor agonists
03/02/2006CA2573371A1 Pyrimidines as plk inhibitors
03/02/2006CA2571132A1 Novel compounds having an anti-bacterial activity
03/01/2006EP1630162A1 2-aminoquinoline derivative
03/01/2006EP1630159A1 5-HT7 receptor antagonists
03/01/2006EP1630158A1 5-HT7 receptor antagonists
03/01/2006EP1628972A1 INDAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS
03/01/2006EP1628970A2 Heterocycle substituted carboxylic acids as inhibitors of protein tyrosine phosphatase-1b
03/01/2006EP1628968A1 4-imidazolin-2-one compounds
03/01/2006EP1628961A1 Phenyl quinolines and their use as estrogen receptor modulators
03/01/2006EP1628957A1 Sulfopyrroles
03/01/2006EP1628949A2 Process and intermediates for preparing benzazepines
03/01/2006EP1628665A2 3-phenyl-4-(pyrimidin-2-yl)-6-(piperidin-4-yl) derivatives and related compounds as tnf-alpha and il-1 inhibitors for the treatment of inflammations
03/01/2006EP1628661A2 Modulators of vr1 receptor
03/01/2006EP1628619A2 4-aminopyrimidine-5-one
03/01/2006EP1628533A2 Chemokine receptor binding heterocyclic compounds with enhanced efficacy
03/01/2006EP1310497B1 Pyrazole derivative, pest control agent comprising the same as active ingredient and process for producing the same
03/01/2006EP1307192B1 Candesartan for treating migraine
03/01/2006EP1278520B1 Diaryl piperidyl pyrrole derivatives as antiprotozoal agents
03/01/2006EP0842923B1 Pyrrole derivatives and medicinal composition
03/01/2006CN1742007A Indole-derivative modulators of steroid hormone nuclear receptors
03/01/2006CN1742005A Indolylmaleimide derivatives
03/01/2006CN1742004A Indazolamides with analgesic activity
03/01/2006CN1741999A Pyridazinone derivatives as GSK-3beta inhibitors
03/01/2006CN1741995A Isoindoline derivative
03/01/2006CN1741992A 大麻素受体配体 Cannabinoid receptor ligands
03/01/2006CN1741986A Amide derivatives and their use as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1
03/01/2006CN1740173A Inhibitors of interleukin-1beta converting enzyme
03/01/2006CN1740170A Prepn process of peptide HIV proteinase inhibitor
03/01/2006CN1740162A Process for the preparation of pesticidal compounds
03/01/2006CN1740151A 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
03/01/2006CN1740150A 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
03/01/2006CN1243752C Herbicidal heterocyclic compound
03/01/2006CN1243751C Piperidine compounds as anti-allergic medicine
03/01/2006CN1243750C 4-,5-,6-and 7-indole derivatives useful for treatment of CNS disorders
03/01/2006CN1243749C Benzimidazole derivatives
03/01/2006CN1243748C Method for carbamoylating alcohols
03/01/2006CN1243735C 2-lminopyrrolidine derivatives
03/01/2006CN1243724C Amide derivatives which are useful as cell factor inhibitors
02/2006
02/28/2006US7005521 Catalytic compositions and methods for asymmetric allylic alkylation
02/28/2006US7005520 cyclization of a 3-amidyl-4-amino-pyrazole compound with n-hydroxy-5-[(4-methylpiperazin-1-yl)sulfonyl]benzenecarboximidamidine compound; anti-impotency drugs
02/28/2006US7005440 Therapeutic uses of tri-aryl acid derivatives
02/28/2006US7005439 Compounds
02/28/2006US7005438 Pharmaceutically active isoindoline derivatives
02/28/2006US7005436 Heterocyclo inhibitors of potassium channel function
02/28/2006US7005435 Lactam-containing compounds and derivatives thereof as factor Xa inhibitors
02/28/2006US7005433 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
02/28/2006CA2331877C Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
02/24/2006CA2533320A1 2, 4-pyrimidinediamines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders
02/23/2006WO2006021002A2 Compounds useful for inhibiting chk1
02/23/2006WO2006020879A1 Isoindolone compounds and their use as metabotropic glutamate receptor potentiators